Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2025-12-25 @ 11:49 PM
Study NCT ID:
NCT00776594
Status:
COMPLETED
Last Update Posted:
2016-10-21
First Post:
2008-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10
Start Date Type:
None
Primary Completion Date:
2014-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-20
First Submit QC Date:
None
Study First Post Date:
2008-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-29
Results First Submit QC Date:
None
Results First Post Date:
2016-08-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-12
Last Update Post Date:
2016-10-21
Last Update Post Date Type:
ESTIMATED